PracticeBlogFlashcardsEspañol
All Practice Exams

100+ Free ABEM Pain Medicine Practice Questions

Pass your Pain Medicine Subspecialty Certification (ABA-administered, ABEM/ABPMR/ABPN) exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
~80-88% (first-time, all primary boards combined) Pass Rate
100+ Questions
100% Free
1 / 100
Question 1
Score: 0/0

Which ascending pathway is the primary route for transmission of nociceptive (pain) signals from the spinal cord to the thalamus?

A
B
C
D
to track
2026 Statistics

Key Facts: ABEM Pain Medicine Exam

~200

Pain Medicine Subspecialty Exam Questions

ABA Pain Medicine Examination Information

~4 hours

Half-Day Exam at Pearson VUE

ABA / Pearson VUE

$2,100

2026 ABA Pain Medicine Exam Fee

ABA 2026 Fee Schedule

12 months

ACGME Pain Medicine Fellowship Required

ACGME Pain Medicine Program Requirements

~80-88%

First-Time Pass Rate (All Primary Boards)

ABA Pain Medicine Exam Statistics

10 years

Subspecialty Certificate Validity

ABA / ABEM Continuous Certification

The Pain Medicine subspecialty certification is administered by the American Board of Anesthesiology (ABA) on behalf of co-sponsoring boards including ABEM (Emergency Medicine), ABPMR (Physical Medicine & Rehabilitation), and ABPN (Psychiatry & Neurology). EM diplomates who complete an ACGME-accredited 12-month Pain Medicine fellowship are eligible for this subspecialty credential through ABEM. The examination is a half-day computer-based test of approximately 200 single-best-answer multiple-choice questions delivered at Pearson VUE testing centers, typically once per year in August-September. The 2026 ABA registration fee is approximately $2,100 plus ABEM diplomate processing fees. Content reflects the multidisciplinary practice of pain medicine: pain pathophysiology and assessment, acute and postoperative pain (multimodal analgesia, PCA, regional blocks, ERAS), chronic non-cancer pain (low back pain red flags, fibromyalgia, osteoarthritis), cancer pain (WHO analgesic ladder, neuraxial opioids, celiac plexus block, breakthrough pain), neuropathic pain syndromes (postherpetic neuralgia, diabetic neuropathy, trigeminal neuralgia, CRPS Budapest criteria, phantom limb), headache and facial pain (triptans, gepants, anti-CGRP mAbs, cluster, medication overuse, GCA), opioid pharmacology and CDC 2022 safe prescribing (MME conversions, equianalgesic tables, methadone QTc, buprenorphine, naloxone co-prescribing, PDMP, UDT), non-opioid analgesics and adjuvants (acetaminophen, NSAIDs, gabapentinoids, TCAs/SNRIs, topicals), interventional procedures (epidural steroid injections, facet/medial branch blocks and RFA, sympathetic blocks, ASRA anticoagulation guidelines), neuromodulation (SCS - tonic/burst/HF10/DTM, DRG stimulation, intrathecal pumps with PACC guidelines), psychological and behavioral approaches (CBT, ACT, MBSR, catastrophizing), and special populations (pediatric FLACC/FACES, geriatric Beers list, pregnancy/lactation safety, OUD with MAT - methadone, buprenorphine, naltrexone). The certificate is valid for 10 years and maintained via ABA MOCA 2.0 or ABEM continuous certification (longitudinal assessment, practice improvement, license, Code of Professionalism).

Sample ABEM Pain Medicine Practice Questions

Try these sample questions to test your ABEM Pain Medicine exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1Which ascending pathway is the primary route for transmission of nociceptive (pain) signals from the spinal cord to the thalamus?
A.Spinothalamic tract
B.Corticospinal tract
C.Dorsal column-medial lemniscus
D.Spinocerebellar tract
Explanation: The spinothalamic tract (specifically the lateral spinothalamic tract) is the principal ascending pathway for pain and temperature. Second-order neurons cross at the spinal level (anterior white commissure) and ascend contralaterally to the VPL of the thalamus. The dorsal columns carry fine touch and proprioception; the corticospinal tract is descending motor.
2C-fibers transmit which type of pain?
A.Slow, dull, poorly localized pain
B.Fast, sharp, well-localized pain
C.Proprioception
D.Light touch
Explanation: Unmyelinated C-fibers carry slow, dull, poorly-localized 'second pain' at conduction velocities of ~0.5-2 m/s. Myelinated A-delta fibers carry fast, sharp, well-localized 'first pain' at 5-30 m/s. A-beta fibers carry light touch and proprioception.
3Per the IASP definition, allodynia refers to:
A.Pain caused by a normally non-painful stimulus
B.Increased pain from a normally painful stimulus
C.Pain in the absence of any stimulus
D.Loss of all sensation in a region
Explanation: Allodynia = pain from a normally non-painful stimulus (e.g., light touch causing pain). Hyperalgesia = increased pain response to a normally painful stimulus. Spontaneous pain = pain without identifiable stimulus. Anesthesia dolorosa = pain in an anesthetic area (often post-neurolysis).
4Wind-up phenomenon in chronic pain is mediated primarily by which receptor in dorsal horn neurons?
A.NMDA receptor
B.GABA-A receptor
C.Mu-opioid receptor
D.Alpha-2 adrenergic receptor
Explanation: Wind-up is a progressive increase in dorsal horn neuron response to repeated C-fiber stimulation, mediated by NMDA receptor activation after Mg2+ block is removed by sustained depolarization. Ketamine (NMDA antagonist) attenuates wind-up and central sensitization, supporting its use in chronic and opioid-tolerant pain.
5The descending pain modulation system originates primarily in which brainstem region?
A.Periaqueductal gray (PAG) and rostral ventromedial medulla (RVM)
B.Substantia nigra
C.Nucleus tractus solitarius
D.Locus coeruleus only
Explanation: The endogenous descending pain modulation system originates in the periaqueductal gray (PAG) and projects via the rostral ventromedial medulla (RVM) to the dorsal horn, releasing serotonin and norepinephrine. This pathway is the molecular basis for SNRI and TCA efficacy in neuropathic pain. Locus coeruleus contributes noradrenergic descending input but is not the primary origin.
6Which of the following best characterizes nociplastic pain?
A.Altered nociception without clear evidence of tissue damage or somatosensory lesion (e.g., fibromyalgia)
B.Pain due to direct tissue injury (e.g., postoperative pain)
C.Pain from a lesion of the somatosensory nervous system (e.g., postherpetic neuralgia)
D.Pain from psychiatric disease only
Explanation: IASP added nociplastic pain in 2017 as a third descriptor: pain arising from altered nociception without clear evidence of tissue damage (nociceptive) or somatosensory nervous system lesion (neuropathic). Fibromyalgia, IBS, and some chronic pelvic pain syndromes are prototypical examples. Treatment emphasizes central-acting agents (SNRIs, gabapentinoids, TCAs) and behavioral therapy.
7Which validated tool screens for opioid misuse risk in chronic pain patients prior to prescribing?
A.Opioid Risk Tool (ORT) or SOAPP-R
B.PHQ-9
C.CAGE-AID alone
D.Wong-Baker FACES
Explanation: The Opioid Risk Tool (ORT, 5 items) and the Screener and Opioid Assessment for Patients with Pain - Revised (SOAPP-R, 24 items) are validated for pre-prescribing risk stratification. The COMM (Current Opioid Misuse Measure) is for monitoring patients already on opioids. CAGE-AID screens for general substance use. PHQ-9 screens for depression.
8Diaphragmatic irritation classically refers pain to which dermatome?
A.C3-C5 (shoulder tip - 'Kehr's sign')
B.T4-T6 (mid-back)
C.L1-L2 (groin)
D.S2-S4 (perineum)
Explanation: The phrenic nerve originates from C3-C5 ('C3, 4, 5 keeps the diaphragm alive') and conveys diaphragmatic afferents. Subdiaphragmatic pathology (splenic rupture, subdiaphragmatic abscess, ectopic rupture, free air) refers pain to the ipsilateral shoulder tip - Kehr's sign. Knowledge of viscerosomatic referral is critical for evaluating pain syndromes.
9The Melzack and Wall gate control theory of pain proposes that activity in which fibers can 'close the gate' and reduce nociceptive transmission at the dorsal horn?
A.Large myelinated A-beta fibers
B.Unmyelinated C-fibers
C.A-delta fibers only
D.Sympathetic postganglionic fibers
Explanation: Melzack and Wall (1965) proposed that large-diameter myelinated A-beta input (touch, vibration) activates inhibitory interneurons in the substantia gelatinosa, reducing transmission of small-fiber (A-delta, C) nociceptive input. This is the theoretical basis for TENS therapy and rubbing an injured area to reduce pain. Spinal cord stimulation conventional (tonic) waveforms are conceptually rooted in gate control.
10Multimodal analgesia for postoperative pain typically combines which of the following to reduce opioid requirements?
A.Acetaminophen, NSAIDs, regional/neuraxial block, gabapentinoids ± low-dose ketamine
B.High-dose opioid monotherapy
C.Benzodiazepines and barbiturates
D.Inhaled anesthetic alone
Explanation: Multimodal (or 'opioid-sparing') analgesia uses agents working at different sites: acetaminophen (central), NSAIDs (peripheral COX), gabapentinoids (alpha-2-delta), regional/neuraxial blocks (afferent block), and sometimes low-dose ketamine (NMDA). This approach is the cornerstone of ERAS protocols and reduces opioid consumption by ~30-50%.

About the ABEM Pain Medicine Exam

The Pain Medicine subspecialty certification is a multidisciplinary credential administered by the American Board of Anesthesiology (ABA) on behalf of co-sponsoring boards including ABEM, ABPMR, and ABPN. Emergency physicians who complete an ACGME-accredited 12-month Pain Medicine fellowship earn the credential through ABEM. The exam consists of approximately 200 single-best-answer MCQs over a half-day at Pearson VUE testing centers and covers acute, chronic, cancer, neuropathic, and interventional pain management. Pain medicine physicians earn a BLS SOC 29-1229 (Physicians, All Other) median wage above $230,000+, with interventional pain practice often exceeding $400,000.

Questions

200 scored questions

Time Limit

Half-day (~4 hours) at Pearson VUE testing centers

Passing Score

Criterion-referenced pass/fail (scaled score by ABA standard-setting)

Exam Fee

$2,100 (ABA Pain Medicine 2026 fee); ABEM application/registration fees additional (American Board of Anesthesiology (ABA) on behalf of ABEM/ABPMR/ABPN; Pearson VUE testing centers)

ABEM Pain Medicine Exam Content Outline

~10%

Pain Pathophysiology & Assessment

Nociceptive vs neuropathic vs nociplastic pain, ascending/descending pathways (spinothalamic, periaqueductal gray, RVM), peripheral and central sensitization, NMDA/AMPA receptors, wind-up, gate control theory, NRS/VAS/FLACC/PAINAD scales, biopsychosocial model, opioid risk tools (ORT, SOAPP-R, COMM).

~10%

Acute & Postoperative Pain

Multimodal analgesia, PCA opioids (morphine 1 mg q6-10 min lockout; hydromorphone 0.2 mg), thoracic epidural for thoracotomy, transversus abdominis plane (TAP) blocks, ERAS protocols, ketamine sub-anesthetic infusions (0.1-0.5 mg/kg/h), acute-on-chronic pain with OUD/MAT, sickle cell vaso-occlusive crisis, burn pain.

~12%

Chronic Non-Cancer Pain

Low back pain red flags (cauda equina, infection, malignancy, fracture), failed back surgery syndrome, fibromyalgia (duloxetine, milnacipran, pregabalin FDA-approved), myofascial pain, osteoarthritis (acetaminophen first-line per ACR/AAOS), chronic pelvic pain, TMD, functional outcomes vs pain scores.

~8%

Cancer Pain

WHO analgesic ladder (Step 3 strong opioids + adjuvants), bone pain (NSAIDs, bisphosphonates, denosumab, palliative radiation), neuraxial opioids/ziconotide via intrathecal pump, celiac plexus block for pancreatic cancer, breakthrough pain (10-20% of around-the-clock dose), end-of-life palliative sedation.

~12%

Neuropathic Pain Syndromes

Postherpetic neuralgia (gabapentinoids, TCAs, lidocaine 5% patch, capsaicin 8%), diabetic peripheral neuropathy, trigeminal neuralgia (carbamazepine first-line; MVD or gamma knife), CRPS I/II Budapest criteria, phantom limb pain, painful HIV neuropathy, central post-stroke pain.

~8%

Headache & Facial Pain

Migraine acute (triptans, gepants, ditans, NSAIDs) and prophylaxis (propranolol, topiramate, anti-CGRP mAbs - erenumab/fremanezumab/galcanezumab/eptinezumab), cluster headache (high-flow O2, sumatriptan SC, verapamil, occipital nerve block), tension-type, medication overuse headache, IIH, GCA (urgent steroids + biopsy).

~12%

Opioid Pharmacology & Safe Prescribing

CDC 2022 Opioid Prescribing Guidelines, MME conversions, equianalgesic tables (morphine 30 PO ≈ oxycodone 20 ≈ hydromorphone 7.5 PO ≈ fentanyl 12 mcg/h patch), incomplete cross-tolerance (reduce 25-50%), QTc with methadone, buprenorphine pharmacology (partial mu agonist), naloxone co-prescribing, PDMPs, urine drug testing interpretation.

~8%

Non-Opioid Analgesics & Adjuvants

Acetaminophen 4 g/day max (3 g in elderly/liver), NSAIDs (COX-2 selectivity, GI/CV/renal risks), gabapentin/pregabalin titration, TCAs (nortriptyline preferred over amitriptyline in elderly), SNRIs (duloxetine, venlafaxine, milnacipran), topical lidocaine and capsaicin, muscle relaxants (cyclobenzaprine, baclofen, tizanidine), cannabinoids.

~12%

Interventional Procedures

Epidural steroid injections (interlaminar/transforaminal/caudal), facet/medial branch blocks → radiofrequency ablation (RFA), sacroiliac joint injections, sympathetic blocks (stellate ganglion, lumbar sympathetic, celiac plexus), peripheral nerve blocks, intradiscal procedures, vertebroplasty/kyphoplasty, ASRA anticoagulation guidelines for neuraxial procedures.

~6%

Neuromodulation & Implantables

Spinal cord stimulation (SCS) for FBSS/CRPS/painful diabetic neuropathy - tonic vs burst vs HF10 (10 kHz) vs DTM, dorsal root ganglion (DRG) stimulation for focal CRPS, peripheral nerve stimulation, intrathecal drug delivery (morphine, ziconotide, baclofen) - PolyAnalgesic Consensus Conference (PACC), trial-to-permanent psychological screening.

~6%

Psychological & Behavioral Approaches

Cognitive behavioral therapy (CBT) for chronic pain, acceptance and commitment therapy (ACT), mindfulness-based stress reduction (MBSR), pain catastrophizing scale (PCS), kinesiophobia (TSK), motivational interviewing, biofeedback, hypnosis, depression/anxiety screening (PHQ-9, GAD-7) and treatment integration.

~6%

Addiction & Special Populations

DSM-5 OUD criteria, MAT (methadone, buprenorphine/naloxone, extended-release naltrexone), perioperative buprenorphine management, pediatric pain (FLACC, FACES, age-adjusted dosing), geriatric pain (start low go slow; avoid Beers list - meperidine, long-acting benzos), pregnancy/lactation safety (acetaminophen first-line; avoid NSAIDs after 20 weeks), palliative care.

How to Pass the ABEM Pain Medicine Exam

What You Need to Know

  • Passing score: Criterion-referenced pass/fail (scaled score by ABA standard-setting)
  • Exam length: 200 questions
  • Time limit: Half-day (~4 hours) at Pearson VUE testing centers
  • Exam fee: $2,100 (ABA Pain Medicine 2026 fee); ABEM application/registration fees additional

Keys to Passing

  • Complete 500+ practice questions
  • Score 80%+ consistently before scheduling
  • Focus on highest-weighted sections
  • Use our AI tutor for tough concepts

ABEM Pain Medicine Study Tips from Top Performers

1Anchor your study plan to the ABA Pain Medicine content outline - the exam is mapped directly to this blueprint, freely available at theaba.org; treat it as your personal checklist and audit your knowledge by section
2Master CDC 2022 opioid prescribing concepts and equianalgesic conversions early - high-yield items include morphine 30 mg PO ≈ oxycodone 20 mg PO ≈ hydromorphone 7.5 mg PO ≈ fentanyl 12 mcg/h patch, the 50 and 90 MME thresholds, methadone QTc monitoring, buprenorphine partial agonist pharmacology, and naloxone co-prescribing for patients on >50 MME
3Memorize the ASRA Pain Medicine anticoagulation guidelines for neuraxial and deep-block procedures - hold times for warfarin (INR ≤1.5), DOACs (apixaban/rivaroxaban 3 days; dabigatran 4-5 days), clopidogrel (5-7 days), and LMWH (12-24 hours depending on dose) appear repeatedly on the exam
4Drill a high-yield question bank daily through fellowship (Pain Exam, Pass Machine, NYSORA modules) - target 2,000-3,000 questions with careful explanation review; track weak areas (often headache pharmacology, intrathecal pump PACC recommendations, pediatric/geriatric dosing) in a spreadsheet and re-test
5Rehearse interventional anatomy with fluoroscopy and ultrasound images - know the safe triangle and Kambin's triangle for transforaminal epidurals, particulate vs non-particulate steroid selection (use non-particulate for cervical and lumbar transforaminal to avoid catastrophic embolic events), and the anatomic landmarks for stellate ganglion (C6 Chassaignac tubercle), celiac plexus (T12-L1), and lumbar sympathetic (L2-L4) blocks

Frequently Asked Questions

Who administers the Pain Medicine subspecialty exam and how is the EM pathway structured?

Pain Medicine is a multidisciplinary subspecialty whose examination is administered by the American Board of Anesthesiology (ABA) on behalf of co-sponsoring boards: ABEM (Emergency Medicine), ABPMR (Physical Medicine & Rehabilitation), and ABPN (Psychiatry & Neurology). EM-trained physicians who complete an ACGME-accredited 12-month Pain Medicine fellowship apply for and receive the certificate through ABEM. The exam itself is identical regardless of primary board - approximately 200 single-best-answer MCQs over a half-day at Pearson VUE testing centers, given annually (typically August-September). The certificate is valid for 10 years.

How is the Pain Medicine exam structured and how long is it?

The ABA-administered Pain Medicine subspecialty examination is a computer-based test delivered at Pearson VUE testing centers across the US. It consists of approximately 200 single-best-answer multiple-choice questions, typically administered as a single half-day session of about 4 hours including a short scheduled break. Questions follow the ABA Pain Medicine content outline and emphasize multidisciplinary practice: pathophysiology, pharmacology (opioid and non-opioid), interventional procedures, neuromodulation, headache, neuropathic pain, cancer pain, addiction, and special populations. Stimulus images include MRI/CT, fluoroscopy views of needle placement, and EMG tracings.

How much does the Pain Medicine subspecialty exam cost for 2026?

The 2026 ABA Pain Medicine subspecialty examination registration fee is approximately $2,100. EM-trained candidates also pay an ABEM application/processing fee (typically $200-$500). Total initial subspecialty cost is approximately $2,300-$2,600 excluding fellowship tuition (most fellowships are funded), question banks, board review courses, and travel. Fees are set annually by the ABA - check theaba.org for the current schedule.

What are the eligibility requirements for the Pain Medicine subspecialty exam through ABEM?

Candidates must hold an MD or DO (or international equivalent) with current primary board certification (ABEM for the EM pathway, or ABA, ABPMR, ABPN, or ABFM via Hospice & Palliative Medicine) AND have successfully completed an ACGME-accredited 12-month Pain Medicine fellowship. Candidates must hold an active unrestricted medical license and agree to the ABEM Code of Professionalism. Applications typically open in early spring with a deadline several months before the August-September exam.

What are the highest-yield topics on the Pain Medicine boards?

High-yield areas on the ABA Pain Medicine exam: opioid pharmacology and CDC 2022 prescribing guideline (MME conversions, equianalgesic tables, methadone QTc monitoring, buprenorphine pharmacology, naloxone co-prescribing); ASRA anticoagulation guidelines for neuraxial procedures; epidural steroid injections (anatomy, technique, complications, particulate vs non-particulate steroid choice for transforaminal); CRPS Budapest criteria; trigeminal neuralgia (carbamazepine first-line); migraine prophylaxis including anti-CGRP monoclonal antibodies; spinal cord stimulator indications and waveforms (tonic, burst, HF10, DTM); pediatric pain assessment (FLACC, FACES); geriatric Beers list pitfalls (meperidine, long-acting benzodiazepines); pregnancy analgesic safety (avoid NSAIDs after 20 weeks); intrathecal pump PACC recommendations; and OUD treatment with MAT (methadone, buprenorphine/naloxone, extended-release naltrexone).

What is the Pain Medicine subspecialty exam pass rate?

Historical first-time pass rates on the ABA Pain Medicine examination range approximately 80-88% across all primary boards combined. EM-trained candidates perform comparably to anesthesiology-, PM&R-, and neurology-trained candidates after completing a 12-month ACGME Pain Medicine fellowship. Overall ultimate pass rates approach 95% within two attempts. Specific year-over-year data is published in the ABA's annual examination statistics report.

How should I prepare for the Pain Medicine subspecialty exam?

Build a structured study plan anchored to the ABA Pain Medicine content outline. Key resources: Practical Management of Pain (Benzon) or Bonica's Management of Pain as canonical references; question banks (Pain Exam, Pass Machine, NYSORA review modules) - aim for 2,000-3,000 questions during fellowship with careful explanation review; ASRA Pain Medicine guidelines (anticoagulation, infection); CDC 2022 Clinical Practice Guideline for Prescribing Opioids; a board review course in the final 3-4 months (ASRA, NYSORA, AAPM); and at least two full-length timed practice exams (~200 questions each). Typical successful candidates invest 200-400 hours of dedicated study combined with fellowship clinical experience and procedural log.

How is the Pain Medicine certificate maintained after passing?

The Pain Medicine certificate is valid for 10 years and maintained via either ABA MOCA 2.0 (for ABA-primary diplomates) or ABEM continuous certification (for ABEM-primary diplomates). EM-trained pain physicians satisfy continuous certification through annual fees, longitudinal assessment (LLSA-style item delivery or equivalent), one practice improvement activity per cycle, an active unrestricted medical license, and agreement to the ABEM Code of Professionalism. Subspecialty recertification requires demonstration of ongoing pain practice and may include subspecialty-specific assessment items.